| Lizenz: Creative Commons Namensnennung 4.0 International (6MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-407203
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.40720
Zusammenfassung
Major depressive disorder is the main cause of disability worldwide with imperfect treatment options. However, novel therapeutic approaches are currently discussed, from augmentation strategies to novel treatments targeting the immune system or the microbiome-gut-brain axis. Therefore, we examined the potential beneficial effects of minocycline, a tetracycline antibiotic with pleiotropic, ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik